L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
64,200
-6,800 (-9.58%)
Jul 20, 2026, 3:30 PM KST
Market Cap1.73T +125.4%
Revenue (ttm)98.10B +34.1%
Net Income-135.14B
EPS-5,627.49
Shares Out 26.97M
PE Ration/a
Forward PE57.25
Dividend50.00 (0.07%)
Ex-Dividend DateDec 29, 2025
Volume286,227
Open69,500
Previous Close71,000
Day's Range61,700 - 71,700
52-Week Range28,150 - 125,000
Beta1.36
AnalystsBuy
Price Target99,000.00 (+54.21%)
Earnings DateAug 14, 2026

About L&C BIO Co.,LTD

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 172
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 290650 stock is "Buy." The 12-month stock price target is ₩99,000, which is an increase of 54.21% from the latest price.

Price Target
₩99,000
(54.21% upside)
Analyst Consensus: Buy
Stock Forecasts